Global New Employee Orientation Workshop
Welcome
1
On-going Networking and Social Events
Job-specific Training
On-the-job Experience and Training
Intranet Orientation Site
New Employee Orientation Workshop
Receipt of Welcome Packet
Job Offer and Acceptance
Interviewing
Recruiting
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
2
Workshop Agenda
Welcome
Participant Introductions
Document Completion
Benefits Information
A Pharmaceutical Company History Video
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
3
Workshop Agenda (continued)
Company Overview
Red Book and Asset Protection
Performance Management/Career Development
Workshop Summary
Wrap-up and Evaluation
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
4
Workshop Objectives
To let you know:
• What is expected of you
• How to add value to the company
• How to communicate with your colleagues
• How to integrate as team players
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
5
Company Overview
6
A Pharmaceutical Company’s Global
Presence
Around the world,
A Pharmaceutical Company:
• Employs more than 31,000 people
• Markets medicines in 179 countries
• Has Research and Development
facilities in 9 countries
• Has Manufacturing facilities in 20
countries
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
7
Our Three Core Values
Respect for people
Integrity
Thirst for excellence
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
8
Our Mission
A Pharmaceutical Company is a research-based
global company
That
Creates pharmaceutical-based health care solutions
To
Enable people to live longer, healthier, more active lives
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
9
Our Four Corporate Objectives
People
Scientific Innovation
Demand Realization
Shareholder Value
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
10
Our Organizational Structure
Policy Committee Charter
At the corporate level, approve and own:
• Performance targets
• Strategies
• Policies
Ensure compliance
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
11
Our Organizational Structure
Policy Committee Activities:
Manage corporate strategy
Allocate resources
Manage corporate assets
Review investments
Review organizational policies
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
12
Our Organizational Structure
Operations Committee Charter
Integrate strategies based on:
• Product
• Geography
• Function
Monitor corporate performance
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
13
Our Organizational Structure
Operations Committee Charter
Identify and discuss corporate:
• Strategic issues
• Operational issues
• Opportunities
Provide for organizational learning
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
14
Our Organizational Structure
Operations Committee Activities:
Review functional, product and geographic plans
Align plans with corporate goals and targets
Monitor corporate performance
Debate strategic issues
Review succession plans
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
15
Global Pharmaceutical Market
North America
33%
Europe,
Middle East
and Africa
31%
Asia and Pacific
5%
Japan
23%
Latin
America
7%
Australia
1%
Sales: $134 Billion U.S. In 1999
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
16
External Factors Affecting the Industry
Disease Focus
Demographics
Decision Maker/
Influencer
Government/
Individual Spending
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
17
Internal Factors Affecting the Industry
Cost
Competition
Regulation
Product Risk
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
18
Pharmaceutical Research Spending
Global (R&D) spending was $24 billion U.S. in 1999
R&D as a percentage of sales was 18 percent
Much higher than other industries:
• 6.4 percent in electronics
• 3.9 percent in aerospace
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
19
Product Risk
10,000 Compounds
Average cost
to develop one drug:
$500 Million U.S.
1,000 Show Promise
100 Are Tested
1
April 4,2000
To Market
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
20
Product Life Cycle
Patent Protection
20 years
Drug Discovery
and Development
Launch
Off Patent
15 years for R&D
and Product
Launch
5 Years
to Recover
R&D costs
Generic
Competition
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
No Longer
Manufactured
21
Drug Development Process
Hypothesis
Generation
Projects
April 4,2000
Candidate
Development
Commercialization
Programs
Products
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
22
Hypothesis Generation
Hypothesis
Generation
Activities
Goal
• Target identification
and validation
• Assay development
Testable,
valuable
hypothesis
• Lead generation
Projects
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
23
Candidate Development
Candidate
Development
Activities
Goal
• Lead optimization
• First human dose
preparation
• Phase IA clinical trials
Proven or
disproven
hypothesis
for given
drug
candidate
• Phase IB / II clinical trials
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
24
Commercialization
Commercialization
Activities
Goal
• Phase III
clinical trials
• Submission
to regulatory
agencies
Successful
commercial
product
• Global launch
Products
April 4,2000
• Global optimization
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
25
Quality, Speed, Value
•
Quality: Working on the best opportunities
•
Speed: Develop drugs in half the time
•
Value: Double the products for every R&D dollar
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
26
Targeted Research Categories
Cancer
Cardiovascular
Central Nervous System
Endocrine
Infectious Diseases
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
27
Current Products
More muscle
• Increase the sales force
• Visit more decision makers more frequently
• Publish more articles
• Increase direct marketing
New indications
Novel delivery devices
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
28
Product Development
New products
• Depression
• Cancer
• Diabetes
• Sepsis
New combinations of existing products
Product partnerships
• Research
• Launch
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
29
A Pharmaceutical Company’s
Manufacturing Processes
Bulk Manufacturing
Raw pharmaceutical
materials are made into
active drug compounds.
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
30
A Pharmaceutical Company’s
Manufacturing Processes
Bulk Manufacturing
Compounds are processed
for storage and proper dosage.
This could include:
Formulation and Filling
April 4,2000
• Mixing inert substances into compounds
• Compressing dry compounds into tablets
• Filling capsules with dry compounds
• Filling vials with liquids
• Freeze-drying liquids for longer storage
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
31
A Pharmaceutical Company’s
Manufacturing Processes
Bulk Manufacturing
Products are prepared
for distribution by:
• Putting them in containers
Formulation and Filling
• Labeling the containers
• Inserting patient instructions
• Placing the containers
in bulk packaging
Finishing (packaging)
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
32
Introduction to Our Intranet
The Company Intranet
The Orientation Site links to:
• Corporate policies and procedures
• Employee benefits and services
• Functional business components
• A Pharmaceutical Company’s product portfolio
• Pharmaceutical industry overview
• Career development resources
April 4,2000
Global New Employee Orientation Company Confidential
Copyright © 2000 Eli A Pharmaceutical Company and
33
Global New Employee Orientation Workshop
Thank You
34